Sanofi: A Good Bet On Pharma

Sanofi: A Good Bet On Pharma


Our DCF analysis shows that there is an upside opportunity of 17% - 54% from the current market price of the shares. Sanofi's stock demonstrated the best return among the major competitors during the one year period.



from Biotech News